aehealth Limited proudly announces that its Lamuno series immunofluorescence analyzer has successfully participated in the National Glycohemoglobin Standardization Program (NGSP) and received certification. This achievement confirms the reliable performance of the Lamuno equipment in the quantitative detection of glycated hemoglobin, ensuring consistency across various laboratories. As a result, Aehealth's glycated hemoglobin analysis and testing platform demonstrates international standardization and quality assurance. This milestone underscores the company's commitment to enhancing its quality improvement processes, reinforcing its position in the global healthcare market. Aehealth continues to advance the reliability and accuracy of its diagnostic tools, further establishing itself as a leader in medical technology